February 24, 2022 Comments Off on New patent for Biofrontera drug AMELUZ Posted in: Patent Added Annual Drug Patent Expirations for AMELUZ Ameluz is a drug marketed by Biofrontera and is included in one NDA. It is available from one supplier. The generic ingredient in AMELUZ…
The post New patent for Biofrontera drug AMELUZ appeared first on DrugPa…
February 24, 2022 Comments Off on New patent for Avion Pharms drug DHIVY Posted in: Patent Added Annual Drug Patent Expirations for DHIVY Dhivy is a drug marketed by Avion Pharms and is included in one NDA. The generic ingredient in DHIVY is carbidopa; levodopa. Additional details…
The post New patent for Avion Pharms drug DHIVY appeared first on …
